Working... Menu
Trial record 4 of 7 for:    bortezomib | glioma | Phase 2, 3

Bortezomib, Temozolomide, and Regional Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00998010
Recruitment Status : Completed
First Posted : October 20, 2009
Last Update Posted : May 7, 2019
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Jonsson Comprehensive Cancer Center

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : April 19, 2018
  Actual Study Completion Date : April 19, 2018